{"id":15259,"date":"2023-12-11T14:05:19","date_gmt":"2023-12-11T12:05:19","guid":{"rendered":"https:\/\/www.impulso.es\/aerospace-perte-and-advanced-healthcare-perte\/"},"modified":"2026-11-06T13:48:14","modified_gmt":"2026-11-06T11:48:14","slug":"aerospace-perte-and-advanced-healthcare-perte","status":"publish","type":"post","link":"https:\/\/www.impulso.es\/en\/aerospace-perte-and-advanced-healthcare-perte\/","title":{"rendered":"Aerospace PERTE and Advanced Healthcare PERTE"},"content":{"rendered":"

[vc_row][vc_column width=”5\/6″][vc_empty_space el_class=”vc_hidden-sm vc_hidden-xs”]

NEW CALL FOR GRANTS FOR THE AEROSPACE PERTE AND ADVANCED HEALTHCARE PERTE WITH UP TO \u20ac513 MILLION.<\/h1>
<\/div>

CDTI has funds of \u20ac240 million and \u20ac273 million, respectively, of which more than \u20ac100 million will correspond to the non-repayable portion (grant)<\/h2><\/div>[vc_column_text css=”.vc_custom_1702309864608{margin-right: 20px !important;margin-left: 20px !important;padding-top: 20px !important;}”]IMPULSO is pleased to inform you that the CDTI has opened the first line of Partially Repayable Grants linked to the Addendum to the Recovery, Transformation and Resilience Plan, approved by the European Commission on October 2, 2023, and focused on the Aerospace PERTE and Advanced Healthcare PERTE<\/strong>, with available funds for these actions totaling \u20ac240 million and \u20ac273 million<\/strong>, respectively, of which more than \u20ac100 million will correspond to the non-repayable portion<\/strong> (equivalent to a grant).<\/p>\n

<\/p>\n

The purpose of these programs is to support investments in the Aerospace and Health sectors through partially repayable loans for the development of R&D&I projects, industrial scale-up, modernization and updating of manufacturing processes, digitalization and technological upgrading, and the development and implementation of sustainable processes.<\/p>\n

Below, we summarize the main features<\/strong> of these grants:<\/p>\n

BENEFICIARIES<\/u><\/strong><\/p>\n

Companies<\/strong>.<\/p>\n

 <\/p>\n

TYPES OF PROJECT<\/u><\/strong><\/p>\n

    \n
  • Individual R&D projects linked to the Addendum and to the Aerospace and Advanced Healthcare PERTEs<\/strong>, of an applied nature for the creation or significant improvement of a production process, product or service. <\/strong>They may include both industrial research and experimental development activities.<\/li>\n
  • Technological innovation projects<\/strong> that support companies in improving their competitiveness<\/strong> through the incorporation of emerging technologies. <\/strong>Their objectives must align with one of the lines identified for the Advanced Healthcare or Aerospace fields.<\/strong> Only projects developed in certain assisted regions<\/strong> will be supported.<\/li>\n<\/ul>\n

     <\/p>\n

    PROJECT REQUIREMENTS<\/u><\/strong><\/p>\n

      \n
    • Project duration:<\/strong> Projects may not<\/strong> finish later than December 31, 2025<\/strong>.\n
        \n
      • R&D projects<\/strong>: minimum duration of 12 months<\/strong>.<\/li>\n
      • Innovation projects<\/strong>: duration between 9 and 24 months<\/strong>.<\/li>\n<\/ul>\n<\/li>\n
      • Minimum budget: \u20ac175,000<\/strong>.<\/li>\n
      • Maximum budget: \u20ac30,000,000<\/strong> (only<\/strong> applicable to Innovation projects; <\/strong>R&D projects have no maximum).<\/li>\n
      • Comply with the DNSH principle.<\/strong><\/li>\n
      • Incentive effect:<\/strong> investments must begin after the grant application has been submitted.<\/li>\n
      • Grant incompatible<\/strong> with other grants.<\/li>\n
      • Minimum contribution<\/strong> from the company to the project budget using its own resources<\/strong>.\n
          \n
        • R&D projects: 10%<\/strong> of the project budget.<\/li>\n
        • Innovation projects: 25%<\/strong> of the project budget.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

           <\/p>\n

          THEMATIC PRIORITIES<\/u><\/strong><\/p>\n

          Aerospace field:<\/u><\/strong><\/p>\n

          This includes everything related to the design, development, manufacturing, operation and maintenance of manned and unmanned aircraft, space vehicles and propulsion systems<\/strong>, as well as the corresponding infrastructure required<\/strong> for their operation (such as airports, air navigation systems, launch sites, or satellite tracking stations) and for carrying out experimentation and testing tasks during their development phases.<\/p>\n

          This field also includes the development of commercial services<\/strong> directly related to aeronautics and space infrastructure.<\/p>\n

          More specifically, the following specific fields<\/strong> have been established:<\/p>\n

            \n
          1. In aeronautics<\/strong>:<\/li>\n<\/ol>\n
              \n
            • Research and development aimed at increasing the efficiency<\/strong> of aircraft and significantly reducing polluting emissions<\/strong> from air transport, including airport infrastructure and air navigation systems that enable more efficient air traffic.<\/li>\n
            • New developments of unmanned aircraft and the software and hardware infrastructure needed<\/strong> for their safe operation in shared airspace.<\/li>\n
            • Onboard systems and equipment<\/strong>.<\/li>\n<\/ul>\n
                \n
              1. In space<\/strong>:<\/li>\n<\/ol>\n
                  \n
                • Design of payloads<\/strong> related to environmental monitoring, quantum communications and security in international cooperation.<\/li>\n
                • Strengthening Spain’s technological capabilities<\/strong> for the commercial use of space (including New Space).<\/li>\n<\/ul>\n
                    \n
                  1. Cross-cutting areas<\/strong>:<\/li>\n<\/ol>\n
                      \n
                    • Sustainability, digitalization and innovation<\/strong> in the aerospace industry, including innovative maintenance systems, such as predictive analysis and real-time monitoring.<\/li>\n
                    • R&D projects whose content represents a significant technological leap<\/strong> or a significant increase in companies’ technological capacity.<\/li>\n<\/ul>\n

                       <\/p>\n

                      Advanced Healthcare field:<\/u><\/strong><\/p>\n

                      This includes the promotion and protection of health through the development and adoption of innovative products, procedures and digital solutions<\/strong> that add value in the<\/strong> prevention, diagnosis, treatment or rehabilitation of patients<\/strong> on a personalized basis.<\/p>\n

                      In general, the cross-cutting areas are:<\/p>\n

                        \n
                      • Maintaining Spain’s leading position<\/strong> in clinical research and retaining investments from pharmaceutical companies.<\/li>\n
                      • Investing in the development, digitalization and modernization of industrial capacity<\/strong> and facilitating the reorientation of production chains toward high-value-added diagnostic, therapeutic and rehabilitative innovation, expanding our industrial autonomy.<\/li>\n<\/ul>\n

                        More specifically, the following strategic objectives<\/strong>:<\/p>\n

                          \n
                        • Promoting personalized precision medicine<\/strong>.<\/li>\n
                        • Development of advanced therapies<\/strong> and other innovative drugs<\/strong>.<\/li>\n
                        • Improvement of prevention, diagnosis, treatment, rehabilitation and health-oriented research<\/strong>, based on the collection, processing, analysis and use of data.<\/li>\n
                        • Digital transformation<\/strong> of healthcare under cybersecurity conditions.<\/li>\n
                        • Addressing a clear technical and care-related need in the field of diagnosis, treatment, rehabilitation and monitoring of conditions<\/strong> in any therapeutic area, where the content represents a technological leap<\/strong>.<\/li>\n<\/ul>\n

                           <\/p>\n

                          ELIGIBLE COSTS<\/u><\/strong><\/p>\n